You are here: Home » Companies » Results
Business Standard

Lupin posts Q3 loss of Rs 152 crore on litigation over blood pressure drug

Lupin reported a one-time charge of Rs 342 crore in Q3


Drugmaker Lupin Ltd posted a surprise quarterly loss on Wednesday after taking a one-time charge related to litigation over a blood pressure drug. Lupin made a provision of Rs 342 crore ($47.7 million) after the General Court of the European Union in December upheld a 2014 European Commission decision on a fine against Lupin related to the blood pressure drug Perindopril, it said. Lupin had a net loss of Rs 152 crore compared to a profit of Rs 222 crore in the same quarter last year, the company said. ALSO READ: Lupin recalls over 24,000 bottles of skin treatment drug from ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, February 06 2019. 14:53 IST